GlassScriptPhysician profile
Ahmed Oudeif
NPI 1538797048
$2,176.46
in general payments reported to CMS, 2019-2025
14 companies · $967 in 2025
The $967 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $433 · 2024: $777 · 2025: $967.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,101 · Education: $75.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,101.33 |
| Education | $75.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $699.79 | 2024-2025 | Optis, Coroflow, Cardiomems |
| Astrazeneca Pharmaceuticals LP | $598.43 | 2023-2025 | Farxiga |
| Penumbra, INC. | $142.91 | 2025 | Indigo System |
| Cardiva Medical, INC. | $141.26 | 2023 | Cardiva Vascade 6/7f Vcs |
| Kestra Medical Technology Services, INC. | $135.27 | 2025 | Assure Wcd |
| Chiesi USA, INC. | $110.29 | 2024-2025 | Kengreal |
| Bridgebio Pharma, INC. | $107.61 | 2025 | Attruby |
| Boston Scientific Corporation | $58.03 | 2023-2025 | Avvigo Guidance System, Rotapro |
| Inari Medical, INC. | $54.34 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shockwave Medical, INC | $36.38 | 2025 | |
| Terumo Medical Corporation | $31.29 | 2023 | Angio-Seal |
| Abiomed | $24.60 | 2025 | |
| Merck Sharp & Dohme LLC | $19.49 | 2023 | Verquvo |
| Novartis Pharmaceuticals Corporation | $16.77 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Oudeif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.